TXG vs MOH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TXG · 10x Genomics$59.28 ▲ 2.10%
MOH · Molina Healthcare$208.99 ▼ 3.53%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TXG +247.1%
- MOH +48.3%
Head to head
| Metric | TXG | MOH |
|---|---|---|
| Price | $59.28 | $208.99 |
| Change today | ▲ 2.10% | ▼ 3.53% |
| Market cap | $7.72B | $10.91B |
| Return, 3 months | +1.2% | +5.1% |
| Return, year to date | +263.5% | +20.4% |
| Return, 1 year | +288.7% | +37.4% |
| P/E (TTM) | – | – |
| P/B | 9.4 | 2.6 |
| P/E percentile vs own 5y | 11th | 0th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -12.6% | -3.4% |
| Net profit growth (YoY) | -151.9% | -51.9% |
| Gross margin | 70.0% | 8.0% |
| Operating margin | -14.9% | 0.6% |
| Net margin | -12.2% | -0.1% |
| Return on equity | -9.4% | -1.2% |
| Analyst target vs. price | +33.6% | +9.1% |
| Analyst buy share | 60% | 29% |
| RSI (14) | 39 | 52 |
| 30-day volatility | 110.7% | 46.0% |
| Max drawdown, 1 year | -40.6% | -39.2% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MOH is the largest of the group by market value.
- TXG has returned the most over the past year.
- MOH is growing revenue fastest.
- MOH keeps the most profit per dollar of sales.
- MOH has been the calmest stock over the last 30 days.